Related Experiment Video

Updated: Apr 27, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K

AIF downregulation and its interaction with STK3 in renal cell carcinoma

Shengqiang Xu1, Hongjin Wu2, Huan Nie2

  • 1School of Life Science and Technology, Harbin Institute of Technology, Harbin, China; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

Plos One
|July 4, 2014
PubMed

Insights

Apoptosis-inducing factor (AIF) is significantly downregulated in most kidney tumors, suggesting its loss contributes to cancer development by impairing programmed cell death. Restoring AIF levels can trigger apoptosis in cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Apoptosis-inducing factor (AIF) is vital for caspase-independent cell death, influencing chromatin condensation and DNA fragmentation.
  • AIF's role in cell homeostasis and tumor development suggests its involvement in cancer pathogenesis.

Purpose of the Study:

  • To investigate the expression levels of AIF in renal cell carcinoma (RCC).
  • To explore the mechanisms and consequences of AIF downregulation in kidney tumors.

Main Methods:

  • Immunohistochemistry and Northern blot analysis were used to assess AIF expression in RCC specimens and kidney tumors.
  • Analysis of AIF deletion and promoter methylation as mechanisms for downregulation.
  • Forced AIF expression in RCC cell lines to observe apoptosis induction.
  • Investigating the interaction between AIF and STK3.

Main Results:

  • Significant AIF downregulation was observed in 84% of RCC specimens (43/51) and other kidney tumors.
  • AIF downregulation resulted from AIF deletion and promoter methylation.
  • Forced AIF expression induced massive apoptosis in RCC cell lines.
  • AIF interacts with STK3, enhancing its phosphorylation at Thr180.

Conclusions:

  • AIF downregulation is a frequent event in kidney tumor development.
  • Loss of AIF may impair STK3 activity, leading to defective apoptosis and malignant transformation.
  • AIF is a potential tumor suppressor in renal cell carcinoma.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

7.6K

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K